摘要
目的探讨电视宫腔镜技术在子宫内膜癌患者早期诊断中的应用价值。方法选取2015年9月至2017年2月间新疆医科大学第五附属医院收治的260例疑似早期子宫内膜癌患者,采用信封式分组的方式分为观察组和对照组,每组130例。观察组患者采用电视宫腔镜技术诊断,对照组患者采用超声检查拟诊和盲探诊断性刮宫检查,比较两组患者的不同病变检出情况、敏感性、漏诊率、特异性及误诊率,并比较两组患者的并发症发生情况。结果观察组患者的黏膜下肌瘤、内膜息肉、内膜萎缩、内膜癌和内膜增生等检出率均高于对照组患者,差异均有统计学意义(均P <0. 05)。观察组患者检查的敏感性与特异性高于对照组,漏诊率与误诊率低于对照组,差异均有统计学意义(均P <0. 05)。观察组患者并发症发生率为1. 5%,低于对照组的6. 9%,差异有统计学意义(P <0. 05)。结论电视宫腔镜技术在子宫内膜癌患者早期诊断中有较高的应用价值,可降低相关并发症发生率,安全性及有效性均较高。
Objective To study the value of TV hysteroscopy in early diagnosis of endometrial carcinoma. Methods A total of 260 patients with suspected early endometrial carcinoma were selected at The Fifth Affiliated Hospital of Xinjiang Medical University from September 2015 to February 2017. The patients were divided into an observation group and a control group with 130 in each group. The patients in the observation group were examined by TV hysteroscopy and patients in the control group were diagnosed by ultrasonography. The detection of different lesions,sensitivity,missed diagnosis rate,specificity and misdiagnosis rate were compared between the two groups. The complications were compared between the two groups too. Results The detection rate of submucosal myoma,endometrial polyp,endometrial atrophy,endometrial carcinoma and endometrial hyperplasia were significantly higher in the observation group than in the control group( all P < 0. 05). The sensitivity and specificity were significantly higher in the observation group than in the control group( all P < 0. 05). The incidence of complications was 1. 5% in the observation group,which was significantly lower than 6. 9% of the control group( P < 0. 05). Conclusion TV hysteroscopy has a high value in the early diagnosis of endometrial carcinoma,and can reduce the incidence of complications,with high safety and effectiveness.
作者
陈海燕
刘雁林
王沛靓
伊婷
杨静
CHEN Hai-yan;LIU Yan-lin;WANG Pei-liang;YI Ting;YANG Jing(Department of Gynaecology,The Fifth Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处
《中国肿瘤临床与康复》
2019年第3期324-326,共3页
Chinese Journal of Clinical Oncology and Rehabilitation